PMA P130024S005

Device
LUTONIX 035 DRUG COATED BALLOON PTA CATHETER
Applicant
Lutonix
PMA number
P130024
Supplement
S005
Product code
ONU
Decision date
2015-11-20
Classification
Drug-eluting Peripheral Transluminal Angioplasty Catheter
Generic name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Approval order statement
APPROVAL FOR THE ADDITION OF THE 7 X 40 MM AND 7 X 60 MM DEVICE SIZES. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME LUTONIX 035 DRUG COATED BALLOON PTA CATHETER AND IS INDICATED FOR PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, AFTER PRE-DILATATION, OF DE NOVO OR RESTENOTIC LESIONS UP TO 150MM IN LENGTH IN NATIVE SUPERFICIAL FEMORAL OR POPLITEAL ARTERIES WITH REFERENCE VESSEL DIAMETERS OF 4-7 MM.

Current openFDA PMA Record#

Device
LUTONIX 035 DRUG COATED BALLOON PTA CATHETER
Applicant
Lutonix
PMA number
P130024
Supplement
S005
Product code
ONU
Generic name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Decision date
2015-11-20
Decision code
APPR
Date received
2015-06-02
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
APPROVAL FOR THE ADDITION OF THE 7 X 40 MM AND 7 X 60 MM DEVICE SIZES. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME LUTONIX 035 DRUG COATED BALLOON PTA CATHETER AND IS INDICATED FOR PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, AFTER PRE-DILATATION, OF DE NOVO OR RESTENOTIC LESIONS UP TO 150MM IN LENGTH IN NATIVE SUPERFICIAL FEMORAL OR POPLITEAL ARTERIES WITH REFERENCE VESSEL DIAMETERS OF 4-7 MM.